These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4348909)

  • 41. The role of endolymphatic radiotherapy in the treatment of chronic lymphatic leukaemia.
    Chiappa S; Bonadonna G; Uslenghi C; Marano P; Molinari R
    Br J Cancer; 1966 Sep; 20(3):480-4. PubMed ID: 4288475
    [No Abstract]   [Full Text] [Related]  

  • 42. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Jan; 161(1):23-9. PubMed ID: 2982221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The endolymphatic therapy using 131-I-lipiodol. Kinetics, indication and technic].
    Peters P
    Nucl Med (Stuttg); 1971; 10(2):150-66. PubMed ID: 4327522
    [No Abstract]   [Full Text] [Related]  

  • 44. [Indications and prospects of endolymphatic radioisotope therapy].
    Speranza N
    Riv Ostet Ginecol; 1969 Dec; 24(12):435-44. PubMed ID: 4327708
    [No Abstract]   [Full Text] [Related]  

  • 45. [Range of application of the endolymphatic radioisotope therapy with P-32 in malignant diseases of the lymphatic system].
    Kärcher KH; Wolf G
    Wien Klin Wochenschr; 1971 May; 83(20):360-2. PubMed ID: 4940209
    [No Abstract]   [Full Text] [Related]  

  • 46. [Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Apr; 161(4):239-43. PubMed ID: 2986321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution pattern of radioactive labelled lipiodol-UF following intralymphatic application for therapy.
    Weissleder H; Pfannenstiel P; Peters PE
    Lymphology; 1976 Sep; 9(3):122-6. PubMed ID: 187879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adenolymphography and endolymphatic radiotherapy in malignant lymphoma].
    Chiappa S; Uslenghi C
    Haematologica; 1973; 58(3):125-34. PubMed ID: 4352621
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic possibilities of isotope lymphography in gynecologic neoplasms. Opinion of Prof. Antonio Onnis].
    Salvati A
    Minerva Med; 1973 May; 64(40):2116-8. PubMed ID: 4719014
    [No Abstract]   [Full Text] [Related]  

  • 50. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 51. Endolymphatic radiotherapy. A comparison of radiogold and radioiodine against the VX2 tumor in the rabbit.
    Lloyd-Davies RW; Edwards JM; Kinmonth JB
    Cancer; 1969 Nov; 24(5):938-44. PubMed ID: 4311113
    [No Abstract]   [Full Text] [Related]  

  • 52. INTRALYMPHATIC RADIOISOTOPE THERAPY.
    SEITZMAN DM; HALABY FA; FLANAGAN P; WRIGHT R; FREEMAN JH
    Surg Gynecol Obstet; 1964 Jan; 118():52-8. PubMed ID: 14105856
    [No Abstract]   [Full Text] [Related]  

  • 53. Selective lymphopenia in man after intralymphatic injection of radioactive 131-I lipiodol.
    Edwards JM; Lloyd-Davies RW; Kinmonth JB
    Br Med J; 1967 Feb; 1(5536):331-5. PubMed ID: 4289356
    [No Abstract]   [Full Text] [Related]  

  • 54. [Radiation therapy of malignant melanoma (author's transl)].
    Scherer E; Makoski HB
    Langenbecks Arch Chir; 1976 Nov; 342():545-8. PubMed ID: 825693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [FIRST RESULTS OF INTRALYMPHATIC RADIOTHERAPY IN MALIGNANT LYMPHOGRANULOMA].
    DIPIETRO S; USLENGHI C
    Tumori; 1965; 51():113-29. PubMed ID: 14337657
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
    Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
    Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
    [No Abstract]   [Full Text] [Related]  

  • 57. [ON THE PHYSICO-BIOLOGICAL PRESUPPOSITIONS OF CLINICAL LYMPHOADENOISOTOPE THERAPY].
    LACONI A; MANESCHI M; MELFI F
    Riv Ostet Ginecol; 1963 Sep; 18():469-74. PubMed ID: 14090129
    [No Abstract]   [Full Text] [Related]  

  • 58. [New methods of supplementary radioisotope use in gynecological oncology].
    Davitti L; Temporelli A
    Minerva Ginecol; 1968 Feb; 20(3):229-41. PubMed ID: 5741556
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of endolymphatic P32 labeled and I-131 labeled lipids in the VX2 involved lymph nodes of the rabbit.
    Lord RS; Kinmonth JB
    Am J Roentgenol Radium Ther Nucl Med; 1968 Aug; 103(4):856-62. PubMed ID: 5677567
    [No Abstract]   [Full Text] [Related]  

  • 60. [Lymphogenous formation of metastases in malignant melanoma].
    Wolf G; Czech W; Pulitzer B
    Radiologe; 1973 Nov; 13(11):485-91. PubMed ID: 4779091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.